SUBSCRIBE
SUBSCRIBE

Nevada

PRESS RELEASES
Press Releases
BioVie Inc. Announces Closing of Registered Direct Offering
October 30, 2024
 · 
4 min read
Press Releases
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 29, 2024
 · 
4 min read
Press Releases
New SPECTREM study findings reveal TREMFYA® (guselkumab) effectively clears overlooked and undertreated plaque psoriasis
October 28, 2024
 · 
17 min read
Press Releases
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
October 25, 2024
 · 
2 min read
Press Releases
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024
October 24, 2024
 · 
4 min read
Press Releases
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
October 24, 2024
 · 
4 min read
Press Releases
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
October 23, 2024
 · 
5 min read
Press Releases
Secura Bio Appoints Charles R. Romp as Its Chief Executive Officer
October 15, 2024
 · 
3 min read
Press Releases
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
October 3, 2024
 · 
2 min read
Press Releases
BioVie Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin
October 2, 2024
 · 
7 min read
Press Releases
BioVie Inc. Announces Closing of Public Offering
September 26, 2024
 · 
4 min read
Press Releases
BioVie Inc. Announces Pricing of Public Offering
September 24, 2024
 · 
5 min read
Press Releases
BioVie Inc. Announces Proposed Public Offering
September 24, 2024
 · 
5 min read
Press Releases
Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress
September 19, 2024
 · 
4 min read
Press Releases
BioVie Secures All Scientific Approvals Needed to Receive Additional $12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Long COVID
September 16, 2024
 · 
8 min read
Press Releases
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
September 3, 2024
 · 
9 min read
Press Releases
Hydreight Reports Record Topline¹ Revenue of $5.59M in Q2-2024 (YOY Increase of 27%) and positive Adjusted EBIDTA¹
August 29, 2024
 · 
10 min read
News
BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting
August 27, 2024
 · 
11 min read
Press Releases
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
August 21, 2024
 · 
2 min read
Press Releases
Ludwig Announces Substantial Corporate Initiatives
August 14, 2024
 · 
2 min read
Load More